Frost & Sullivan: Miniaturization of Medical Devices Reduces Mortality Rates among Cardiac Dysrhythmia Patients

Frost & Sullivan: Miniaturization of Medical Devices Reduces Mortality Rates among Cardiac Dysrhythmia Patients PR Newswire MOUNTAIN VIEW, California, Nov. 1, 2012 - Increasing end-user awareness of therapy options boosts adoption of medical devices MOUNTAIN VIEW, California, Nov. 1, 2012 /PRNewswire/ -- The rising incidence of acute cardiac rhythm-related disorders is prompting device manufacturers to innovate their cardiac rhythm management (CRM) devices. Technological advances such as device miniaturization, development of smaller durable batteries, and biocompatible materials casing enhances patient comfort and reduces mortality and morbidity rate in patients. New analysis from Frost & Sullivan's (http://www.technicalinsights.frost.com) Cardiac Rhythm Management (CRM) Devices—Demand to Manage Global R&D Efforts research finds that less invasive procedures and constant product updates drive the adoption of CRM devices. If you are interested in more information on this research, please email Britni Myers, Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country. The latter part of the 20th century witnessed a revolution in medical devices with smaller, superior features and capabilities.